Santiago Arroyo
Director/Board Member bei H. LUNDBECK A/S
Vermögen: 971 100 $ am 31.03.2024
Profil
Derzeit hat Santiago Arroyo die Position des Chief Medical Officer & Senior VP-Development bei Momenta Pharmaceuticals, Inc. inne. Dr. Arroyo ist außerdem Mitglied des Vorstands von H. Lundbeck A. Dr. Arroyo hatte zuvor die Position des Chief Medical Officer-Biotherapeutics bei Pfizer Inc. inne, die des Chief Medical Officer bei Boston Pharmaceuticals, Inc. und die des Head-Neurosciences & Discovery Medicine bei Bristol Myers Squibb Co. sowie die des Head-Global Clinical Development bei Eisai Co. Ltd. und war Associate Professor am Hospital Clnic de Barcelona und Associate Professor am The Medical College of Wisconsin, Inc. Santiago Arroyo erhielt einen Doktortitel von der Universidad Autnoma de Madrid und einen Doktortitel von der Universität Barcelona.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
06.02.2024 | 39 000 ( 0,13% ) | 971 100 $ | 31.03.2024 |
Aktive Positionen von Santiago Arroyo
Unternehmen | Position | Beginn |
---|---|---|
H. LUNDBECK A/S | Director/Board Member | 23.03.2021 |
BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 31.03.2023 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Director/Board Member | 02.05.2023 |
Ehemalige bekannte Positionen von Santiago Arroyo
Unternehmen | Position | Ende |
---|---|---|
MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 13.11.2022 |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.05.2017 |
PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01.10.2015 |
EISAI CO., LTD. | Corporate Officer/Principal | 01.01.2007 |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Santiago Arroyo
University of Barcelona | Doctorate Degree |
Universidad Autónoma de Madrid | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 7 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
PFIZER, INC. | Health Technology |
EISAI CO., LTD. | Health Technology |
H. LUNDBECK A/S | Health Technology |
MARINUS PHARMACEUTICALS, INC. | Health Technology |
BICYCLE THERAPEUTICS PLC | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Health Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Health Technology |